ACOG
Alpha Cognition Inc
NASDAQ: ACOG · HEALTHCARE · BIOTECHNOLOGY
$5.87
-5.32% today
Updated 2026-04-29
Market cap
$127.81M
P/E ratio
—
P/S ratio
12.51x
EPS (TTM)
$-1.18
Dividend yield
—
52W range
$5 – $12
Volume
0.1M
Alpha Cognition Inc (ACOG) Earnings
Quarterly earnings history, analyst estimates, and stock price reaction.
EPS beat streak
5 of 8
Last 8 quarters
Avg EPS surprise
+40.7%
Last 4 quarters
Revenue YoY growth
—
Most recent quarter
EPS YoY growth
+38.0%
Most recent quarter
Earnings surprise history (last 12 quarters)
Beat estimate Missed estimate
Quarterly EPS and revenue trend
Quarterly revenue EPS (diluted)
How the stock reacts to earnings
Avg 1-day reaction
-1.7%
Last 2 reports
Positive reaction rate
0%
0 of 2 quarters
Largest single-day move
-2.9%
2025-11-13
| Report date | EPS actual | Surprise | Close before | Close after | 1-day reaction |
|---|---|---|---|---|---|
| 2026-03-27 | $-0.31 | +11.4% | $5.34 | $5.32 | -0.4% |
| 2025-11-13 | $-0.30 | +63.4% | $6.12 | $5.94 | -2.9% |
Quarterly earnings history
| Fiscal quarter ending | EPS estimate | EPS actual | Surprise | Revenue | YoY revenue |
|---|---|---|---|---|---|
| 2025-12-31 | $-0.35 | $-0.31 | +11.4% | $2.79M | — |
| 2025-09-30 | $-0.82 | $-0.30 | +63.4% | $2.84M | — |
| 2025-06-30 | $-0.74 | $-0.65 | +12.2% | $1.66M | — |
| 2025-03-31 | $-0.54 | $-0.13 | +75.9% | $2.93M | — |
| 2024-12-31 | $-0.48 | $-0.50 | -4.2% | — | — |
| 2024-09-30 | — | $-0.31 | — | — | — |
| 2024-06-30 | $-1.00 | $-0.25 | +75.0% | — | — |
| 2024-03-31 | — | $-0.87 | — | — | — |
| 2023-09-30 | — | $-0.86 | — | — | — |
| 2023-06-30 | — | $-0.74 | — | — | — |
| 2023-03-31 | — | $-0.60 | — | — | — |
| 2022-12-31 | — | $-1.52 | — | — | — |
Frequently asked questions
Has Alpha Cognition Inc beaten earnings estimates?
Alpha Cognition Inc has beaten Wall Street EPS estimates in 5 of its last 8 quarterly reports, with an average EPS surprise of +40.7% over the last 4 quarters.
How does ACOG stock react to earnings?
ACOG stock has moved an average of -1.7% in the trading day following earnings over its last 2 reports, with positive reactions in 0% of those quarters.